Prescription drug · UNAPPROVED DRUG OTHER
Sodium Sulfacetamide And Sulfur NDC 44523-748
sodium sulfacetamide 9.8% and sulfur 4.8% · Sulfacetamide sodium 98 mg/g; Sulfur 48 mg/g · Emulsion · Topical · BioComp Pharma, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 44523-748-10 | 44523074810 | 285 g in 1 BOTTLE, PLASTIC (44523-748-10)Marketed from Dec 17, 2024 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Sodium Sulfacetamide And Sulfur
- Generic name (nonproprietary)
- sodium sulfacetamide 9.8% and sulfur 4.8%
- Active ingredients
- Sulfacetamide sodium — 98 mg/gSulfur — 48 mg/g
- Dosage form
- Emulsion
- Route
- Topical
- Labeler
- BioComp Pharma, Inc.
- Product type
- Prescription drug
- Marketing category
- Unapproved drug (other)
- Marketing start
- Listing expires
- Other FDA classes
- Sulfonamides (Chemical structure)
- Identifiers
- Product ID 44523-748_36d7f15d-0115-a647-e063-6394a90ab97dSPL ID 36d7f15d-0115-a647-e063-6394a90ab97dSPL set ID 1ba8bb47-6f7a-28ec-e063-6394a90a8eb3RxCUI 1494169UNII 4NRT660KJQ, 70FD1KFU70
- Pharmacologic class
- Sulfonamide Antibacterial
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N444523074810followed by a unit qualifier and the quantityPackage 44523-0748-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS: This product is indicated for use in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis.
Excerpt only. Read the full label for complete information.